BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Díez-Villares S, Pellico J, Gómez-Lado N, Grijalvo S, Alijas S, Eritja R, Herranz F, Aguiar P, de la Fuente M. Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging. Int J Nanomedicine 2021;16:5923-35. [PMID: 34475757 DOI: 10.2147/IJN.S316767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Bidan N, Lores S, Vanhecke A, Nicolas V, Domenichini S, López R, de la Fuente M, Mura S. Before in vivo studies: In vitro screening of sphingomyelin nanosystems using a relevant 3D multicellular pancreatic tumor spheroid model. Int J Pharm 2022;:121577. [PMID: 35167901 DOI: 10.1016/j.ijpharm.2022.121577] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Jatal R, Mendes Saraiva S, Vázquez-vázquez C, Lelievre E, Coqueret O, López-lópez R, de la Fuente M. Sphingomyelin nanosystems decorated with TSP-1 derived peptide targeting senescent cells. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Masoumi F, Saraiva SM, Bouzo BL, López-López R, Esteller M, Díaz-Lagares Á, de la Fuente M. Modulation of Colorectal Tumor Behavior via lncRNA TP53TG1-Lipidic Nanosystem. Pharmaceutics 2021;13:1507. [PMID: 34575588 DOI: 10.3390/pharmaceutics13091507] [Cited by in F6Publishing: 1] [Reference Citation Analysis]